Proof of cOncept Study demonStrating the potential substitutIon of suBcutaneous Injection of recombinant human insulin by subLIngual administration of S.L.I.M®-Formulations in TYpe-I DIABEtic PaTiEntS
Living with type 1 diabetes means needing insulin every day, usually through skin injections or a wearable pump. This clinical trial explores a needle-free alternative. It tests an experimental treatment called S.L.I.M®, which delivers insulin under the tongue (sublingually). Researchers want to see if insulin absorbed through the mouth can safely reach the bloodstream and control blood glucose as effectively as an injection. For this early study, the research team is inviting adult men aged 18 and over who have type 1 diabetes and currently use an insulin pump. Because this is an early 'proof-of-concept' study, participants will be closely monitored in a clinic to track their blood sugar levels and see how the body handles the medicine. The findings will help scientists understand whether under-the-tongue insulin could one day offer a simpler, pain-free choice for diabetes management.
At a glance
What is this study about?
Type 1 diabetes is a lifelong condition where the body cannot make its own insulin. To stay healthy, people must take insulin every day to manage their blood sugar levels. Currently, insulin has to be given under the skin using daily injections or an insulin pump. While these treatments work well, living with frequent injections and pump sites can be tiring, uncomfortable, and demanding.
This trial investigates a potential breakthrough: giving insulin under the tongue using a special formula known as S.L.I.M®. The tissue under the tongue has a rich blood supply, which can allow certain medicines to enter the bloodstream directly without needing to be swallowed or injected. Researchers want to prove whether this method can deliver enough active insulin to lower blood sugar safely.
Because this is an early Phase 1 trial, the main aim is not to cure diabetes, but to test the biology of how the drug works in humans. If the study shows positive results, it could open the door to larger trials and bring us closer to a practical, needle-free insulin option in the future.
Key takeaways
- Tests a new insulin formulation taken under the tongue instead of through an injection.
- Open to adult men aged 18 and older with type 1 diabetes who use an insulin pump.
- Takes place in a specialised medical clinic with continuous safety and blood sugar monitoring.
- Aims to check how well the body absorbs under-the-tongue insulin compared to standard treatments.
- Taking part is voluntary and will not replace your regular day-to-day diabetes care.
Who may be eligible?
This trial is specifically looking for adult men aged 18 and older who have type 1 diabetes. To take part, you must currently manage your blood sugar using an insulin pump.
Because this is an early safety study, the researchers need a very specific group to minimise variables. Women and children are not being recruited for this particular phase of testing.
People with certain other health issues, such as recent severe hypoglycaemia (very low blood sugar), significant heart or kidney problems, or active mouth conditions that might prevent the medicine from absorbing properly, may not be able to join. The study team will run health checks to make sure taking part is safe for you.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- You are male and aged 18 or older.
- You have been diagnosed with type 1 diabetes.
- You currently use an insulin pump to manage your condition.
- You do not have severe mouth ulcers or conditions affecting your tongue.
- You are able to attend appointments at the research clinic.
What does participation involve?
If you take part, you will first attend a screening visit where doctors review your medical history, check your general health, and test your blood. During the active study days, you will visit a specialist clinical research unit. Medical staff will closely monitor your blood sugar and temporarily pause or adjust your usual insulin pump settings so they can test the under-the-tongue dose. The team will take regular, small blood samples over several hours to measure how quickly the insulin enters your blood and how it affects your glucose levels. Once testing is complete, you will return to your normal insulin routine. The study team will explain the exact number of visits, testing hours, and follow-up checks before you agree to join.
Potential risks and benefits
Locations (1)
- —UnverifiedFrance
Common questions
Will I be able to stop using my insulin pump permanently?
No. This trial is only testing single doses of an experimental treatment in a clinic. Outside the study visits, you will continue using your regular insulin routine.
Does taking insulin under the tongue hurt?
No. The medicine dissolves under the tongue without needles. Some people may notice a slight taste or mild tingling in the mouth.
Why is this trial only open to men?
Early Phase 1 studies often start with a very specific, uniform group to reduce biological differences while testing basic drug absorption. If successful, later trials will include a wider range of people.
What happens if my blood sugar drops too low during the test?
You will be in a specialised clinic with medical staff present at all times. They will monitor your glucose closely and have fast-acting glucose ready to treat any low blood sugar immediately.
Do I have to pay to take part in this research?
No. All trial medicines and tests are provided for free, and clinical studies usually cover reasonable travel expenses.
How to find out more
Always speak to your GP or specialist before deciding to take part in a study.
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.